A carregar...
Cutaneous adverse events in multiple sclerosis patients treated with daclizumab
OBJECTIVE: To analyze the spectrum and mechanisms of cutaneous adverse events (AEs) in patients with multiple sclerosis treated with daclizumab high-yield process (DAC-HYP). METHODS: A total of 31 participants in an institutional review board–approved open-label phase I study of DAC-HYP (NCT01143441...
Na minha lista:
| Publicado no: | Neurology |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Lippincott Williams & Wilkins
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4793779/ https://ncbi.nlm.nih.gov/pubmed/26843560 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/WNL.0000000000002417 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|